Managing the Chronic Pain Patient. (and some stuff about opioids)

Similar documents
SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

Monte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID

Non-Opioid Drugs to Treat Neuropathic Pain. March 2018

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Knock Out Opioid Abuse in New Jersey:

Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation

Neuropathic Pain in Palliative Care

If Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017

Treating Pain and Depression

Learning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16

Conflicts of Interests: None

An unpleasant sensory and emotional experience associated with actual or potential tissue damage.

Neuropathic Pain and Pain Management Options. Mihnea Dumitrescu, MD

Steven Richeimer, M.D.

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

A Patient s Guide to The Medication Approach to Chronic Pain

Neuropathic Pain. Scott Magnuson, MD Pain Management of North Idaho, PLLC

Pain CONCERN. Medicines for long-term pain. Antidepressants

Interprofessional Webinar Series

Chronic Pain: Advances in Psychotherapy

Overview of Neuropathic pain

Medications for the Treatment of Neuropathic Pain

Recognizing Narcotic Abuse and Addiction and Helping Those With It

UCSD DEPARTMENT OF ANESTHESIOLOGY

Syllabus. Questions may appear on any of the topics below: I. Multidimensional Nature of Pain

Managing Pain in the Elderly

Non-opioid and adjuvant pain management

Moving On : Non-Opioid Alternatives for Chronic Pain Management

Pharmacological and Nonpharmacological Approaches

Pain Management: Overview of A Practical Approach

Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am

A Patient s Guide to Fibromyalgia

1) On a scale of 1 10, how would you rate your pain Most of the time, 0 being pain free and 10 being most severe?

Depression After Traumatic Brain Injury (TBI)

CHAPTER 4 PAIN AND ITS MANAGEMENT

8/6/18. Definitions. Disclosures. Technician Objectives. Pharmacist Objectives. Chronic Pain. Non-Opioid Alternatives for Chronic Pain Management

Fibromyalgia summary. Patient leaflets from the BMJ Group. What is fibromyalgia? What are the symptoms?

Winter Meeting February 10, 2018

Fibromyalgia can be painful and make you feel miserable. Fortunately there are treatments that can reduce pain and help you get on with life.

Other classical forms of neuropathic pain include diabetic peripheral neuropathy, trigeminal neuralgia and postherpetic

No disclosures for any of the speakers!

Pharmacological treatment of Pain

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Practical Management Of Osteoporosis

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

Neuropathic Pain Treatment Guidelines

See Important Reminder at the end of this policy for important regulatory and legal information.

5.9. Rehabilitation to Improve Central Pain

Clinical Education Initiative HIV OPIOID/ PAIN MANAGEMENT STRATEGIES. Speaker: Wayne E. Anderson, DO, FAHS, FAAN

Evidence-based Clinical Practice Guidelines on Management of Pain in Older People Aza Abdulla, Margaret Bone, Nicola Adams, Alison M.

9/30/2017. Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management. Program Objectives. Impact of Poorly Managed Pain

Avera ecare Chronic Pain Management Janell Simpkins MD, FACP Avera ecare Specialty Clinic Medical Director

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Management of Pain related to Spinal Cord Lesion

See Important Reminder at the end of this policy for important regulatory and legal information.

Ohio s Prescribing Guidelines for Acute Pain

Scottish Medicines Consortium

Anticonvulsant Prior Authorization Request

10/19/12. Moving from Mechanisms to Treatment in Chronic Pain Patients. Daniel Clauw, MD Disclosures

Current Pharmacotherapy of Chronic Pain

Disclosures. Objectives 9/8/2015

Understanding pain and mental illness Impact on management principles

Pain as a diagnosis and comprehensive management. Peter Stiles, MD Medical Director TRIA Pain Program

Principles of Pain Management for the PCP. Andréa Sciberras, DO, AAHIVS, FACOI, FACP Sciberras Internal Medicine, Inc. Dania Beach, FL 33004

A Patient s Guide to Pain Management Medications

Treatments for Common Pain Disorders. Matthew R. Kohler, MD Hudson Spine and Pain Medicine 03/01/2017

Multidisciplinary Approach to Spine Care. Roland Kent, MD Axis Spine Center Post Falls, Idaho

POLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy

Opioids in Pain and Addiction

10/08/59 PAIN IS THE MOST COMMON TREATABLE SYMPTOM OF CANCER CURRENT EVIDENCE BASED CONCEPTS: MANAGEMENT OF CANCER PAIN PAIN AN UNMET CLINICAL NEED IN

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Foundations of Safe and Effective Pain Management

CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS. Stroke Rehabilitation Evidence Tables Rehabilitation to Improve Central Pain

Spine University s Guide to Fibromyalgia

Index. G Geriatric depression scale (GDS), 25, 139

Headaches, 37, 42 Hypnotherapy, 101t, 106 Hypothalamic-pituitary-adrenal (HPA) axis, 59, 61, 63, 64, 65

Topic 2: The Stress-Vulnerability Model of Co-occurring Disorders

Tips for Managing Acute Pain

COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT

New Guidelines for Prescribing Opioids for Chronic Pain

Strategies in Migraine Care

Striking a Balance: a provider perspective.

UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14. Cynthia Kim and Stephen Wilson

Depakote for pain management

Getting at the CORE of Low-back pain Treatment Dr. John Flannery Dr. Carlo Ammendolia

Clinical and Contextual Evidence Reviews

TUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Neuropathic Pain

Disclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws

Fran Pulver, MD - PM&R Laurie Bell, PT - Physical Therapy Gregg Weidner, MD - Anesthesia Steven Severyn, MD, MBA, MSS - Anesthesia

Gabapentin to treat neuropathy

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014

Agenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures

OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS

National Horizon Scanning Centre. Pregabalin (Lyrica) for fibromyalgia. September 2007

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment

pdpn early screening and management

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

ADJUVANT PAIN MANAGEMENT

Achieving Optimal Therapeutic Outcomes in Pain Management from a Pharmacist's Perspective

Opioid Use and Misuse in Older Adults. Alison Moore, MD, MPH Division of Geriatrics and Gerontology

Transcription:

Managing the Chronic Pain Patient. (and some stuff about opioids) C. Patrick Carroll, M.D. Assistant Professor Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences

Chronic pain is very weird Often no discernible pathology Clinical/pathologic correlation can be poor Massive inter-individual variation in pain processing Conditions defined by pain with few/no other findings

Most get better, but some really don t... STOP-Pain waitlist Pain duration >2 years in 90% >10 in over 25% Usual pain >7/10 in ~60% Very high levels of interference ~50% with moderate to very severe Beck Depression Inventory scores 2/3 with moderate-severe anxiety 50% on short-acting opioids, 25% on long-acting Anxiety, depression, and anger all increased during the wait time

Who is it that's hurting? Multiple comorbidities (often other painful conditions) Highly comorbid with major depression and anxiety Likely mutually causative When found together, really must be treated together Comorbidities explain a lot of the disability High utilizers of medical services (but highly skewed)

Pathology and Pain In knee OA, very modest concordance between radiologic severity and pain in multiple studies. There may be more consistency within individuals However, those with pain and no radiologic OA are very likely to develop OA on long-term followup In low back pain, scans are mostly useless. (unless there's clear neurological threat or signs of a specific condition) Odds ratios ~ 1.2 to 3.3 for low back pain : disc degeneration No association with spondylosis or spondylolisthesis. (26) In some cases, complete lack of (detectable) pathology is expected. Phantom Limb Pain Fibromyalgia

The 2 nd or 3 rd Slide Coghill, et al. PNAS July 8, 2003 vol. 100 no. 14

Diagnosis based treatment for long-term (particularly refractory) chronic pain doesn t work very well.

The Approach Assess the patient before you assess the pain What is his/her prior level of function? What is his/her current level of function? How can you explain the difference? Screen for depression, anxiety, and substance use disorders. What is the patient's attitude toward his symptoms? What are his expectations about treatment?

The Approach Divide the pain symptoms into logical categories that guide (and are also guided by) intervention Especially helpful if there is a pathophysiologic/syndromic intervention If there is a syndromic treatment, do not neglect it. Use symptomatic treatments strategically. Ignore comorbidities, particularly psychiatric ones, at your peril. Common things are always common.

The Approach Think strategically Think ahead Define failure criteria Define success criteria Remember Osler's Rules Be realistic about your tools For chronic pain, treatment effects tend to be modest and optimal management requires use of multiple techniques. Don't do too many things at once. You will never know what worked and what didn't.

The PharmacalogicalTool Kit Pharmacology NSAIDs SNRIs/TCAs (and maybe some other antidepressants) Gabapentinoid Anticonvulsants Opioids Topicals Capsaicin Lidocaine Anesthesia Stuff Ketamine Intrathecals Steroids

Antidepressants All the antidepressants that work for pain seem to work on both serotonin and norepinephrine Venlafaxine Desvenlafaxine Milnacipran Duloxetine Special Case: Tricyclic Antidepressants may also stabilize peripheral nerve cells.

Anticonvulsants Pregabalin (Lyrica) and Gabapentin (Neurontin) have the best safety and efficacy balance so far. Carbamazepine (Tegretol), Topiramate (Topamax), lamotrigine (Lamictal), and several others also work. At least partly work by changing how neurotransmitters work in the spinal cord. Effects are additive with SNRIs

This is where the slides that shows Pat isn t lying would be.

Cage Match: TCA vs. Opioid Postherpetic Neuralgia NRTP vs. Morphine vs. PBO Crossover design High dropout (>40%) Morphine 1.9 points, TCA 1.4 points More cognitive problems in TCAs (avg age >70) Raja et al, Neurology 2002

Central Analgesics Not Fast on, fast off drugs Tend to change the slope of the pain line. Can take several days to weeks to really kick in, and this can be dose-dependent. Need to be used for long times at adequate doses before declaring failure.

Nonpharmacologic Treatments Physical Therapy Disuse Imbalances Abnormal Gait and Posture Acupuncture Biofeedback Relaxation Training CBT

Other interventions Operant Behavioral therapies Cognitive Behavioral therapies E.g. Acceptance based Physical Therapy

Nonpharmacologic Treatments (Linton review) Behavioral treatments for nonheadache pain Poor evidence in general Behavioral treatments improve function and reduce drug consumption Cognitive treatments are unproven Multimodal systems seem to work, but there is no consistent multimodal model.

Nonpharmacologic TreatmentsThieme et al) Fibromyalgia The operant method leads to increased activity levels and decreased pain and drug intake, The relaxation approach results in decreased EMG levels and some pain reductions, Cognitive techniques are speculative at this time, The multimodal method regularly produces a variety of improvements, but the diversity of the treatments makes general statements about utility impossible.

Interventional Generally best used for Diagnosis Temporary relief to facilitate another therapy or goal Cure

Summing Up Assessing the patient is priority one, assessing the pain is priority two. When assessing the pain, don't be surprised to find more than one. Divide into useful categories (not necessarily finegrained diagnoses). Treat syndromically if you can.

Summing Up When treating symptomatically: Don't do too many things at once Use enough for long enough Have success and failure criteria set in advance Include function Be realistic (including with the patient)

Opioids Do they work? Do they make people worse? Are the behavioral effects relevant? Is there anything better?

Do they work? Yes. (... for what we test for.)

What we test them for Six weeks or less Often in patients already exposed/tolerant High dropout rate Lots of adverse events Fairly high treatment failure Pain intensity as the major outcome Overall evidence about function, QOL inconclusive Outcomes Absolute reduction Percent reduction (Pain tends to get better)

Over the long run (10 years) (Jensen et al) Opioid users look worse: Lower HRQOL More depressive symptoms More negative and passive coping But dose increases were about as frequent as decreases Adjuvants discontinued often. Hospitalizations decreased.

Do they make people worse? Opioid-induced Hyperalgesia The idea that opioids can worsen pain Typically seen in case reports High doses Fast titrations Reverses with rotation, reduction, or NMDA antagonists In migraine, opioids are associated with conversion to chronic daily headache People on opioids don t generally have insensitivity to pain on testing.

Simplified schematic model illustrating the putative neuroadaptative continuum model linking sensitization, apparent tolerance, and hyperalgesic withdrawal symptom. Célèrier E et al. J. Neurosci. 2001;21:4074-4080 2001 by Society for Neuroscience

Addiction and Pain Fishbain et al 1992 (review):... only seven studies utilized acceptable diagnostic criteria...... the prevalence percentages for the diagnoses... were in the range of 3.2-18.9%. Reid et al 2002: Prescription opioid abusive behaviors were recorded for 24% of VA and 31% of PCC patients. [emphasis mine]

Addiction and Pseudoaddiction Reward Behavior Pain

Addiction and Pseudoaddiction Reward Behavior Opioid Pain

Who gets addicted? Younger exposure Male Psychiatric illness Antisocial personality/traits Family history of addictions Prior personal history of addictions Screening Instruments for aberrant opioid use behaviors read like a screen for these conditions E.g. SOAPP-R

What do you do about it? There is no real evidence base for dealing with patients with pain and aberrant drug use behaviors Opioid contracts often are used as an exit strategy, but seldom address treating the patient Patient engagement and participation is a major barrier Probably the best management strategy right now is engagement in an intensive, comprehensive, multimodal pain management program. Finding such a place with the philosophical orientation needed to manage such patients is a challenge.